Vara

Developed, tested, and proven in Germany, Vara is a leading AI-powered breast cancer screening company on a mission to find every deadly breast cancer early. Vara’s Artificial Intelligence (AI) technology is embedded within the German Breast Cancer Screening Program and is backed by some of the most respected institutions in breast cancer screening in the world including Cambridge (UK), Memorial Sloan (US), and Karolinska (Sweden). Vara’s clinical evidence has also been published in Lancet Digital Health, demonstrating that Vara-assisted radiologists significantly outperform average radiologists and are able to find cancers that would otherwise have been missed. Vara works with healthcare stakeholders, radiology service providers, and medical doctor networks to improve access to high-quality screening in Germany, Egypt, India and Mexico.

Vara headquartered in Europe, operates in the Artificial Intelligence (AI), Machine Learning, Health Care, Health Diagnostics sector. The company focuses on Artificial Intelligence (AI) and has secured $1.5B in funding across 96 round(s). With a team of 11-50 employees, Vara is actively contributing to advancements in Artificial Intelligence (AI). Their latest funding round, Series A - Vara, raised $Unknown amount. Discover more about their projects, partnerships, and impact on our platform.